Explore
Validate
Learn
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA054200 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA054200, RRID:AB_2682415
- Product name
- Anti-VTCN1
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human VTCN1, Gene description: V-set domain containing T cell activation inhibitor 1, Alternative Gene Names: B7-H4, B7H4, B7S1, B7X, FLJ22418, Validated applications: ICC, IHC, Uniprot ID: Q7Z7D3, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Pharmacologic Suppression of B7-H4 Glycosylation Restores Antitumor Immunity in Immune-Cold Breast Cancers
Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis
Song X, Zhou Z, Li H, Xue Y, Lu X, Bahar I, Kepp O, Hung M, Kroemer G, Wan Y
Cancer Discovery 2020;10(12):1872-1893
Cancer Discovery 2020;10(12):1872-1893
Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis
Wang Y, Zhang Y, Jiang W, Chen Y, Xu S, Liu N, Zhao Y, Li L, Lei Y, Hong X, Liang Y, Li J, Zhang L, Yun J, Sun Y, Li Y, Ma J
Journal for ImmunoTherapy of Cancer 2019;7(1)
Journal for ImmunoTherapy of Cancer 2019;7(1)
No comments: Submit comment
No validations: Submit validation data